Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.58 |
| ▸ | GSR | P00390 | 1/20 | 0.54 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.52 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.48 |
| ▸ | CPB2 | Q96IY4 | 8/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.41 |
| ▸ | GNPAT | O15228 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | GGT1 | P19440 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL48407 | 1.00 | FOLH1 (0.58) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| SCHEMBL48406 | 1.00 | FOLH1 (0.58) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| Hydrochloric Acid SCHEMBL4067569 | 0.98 | FOLH1 (0.56) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| Hydrochloric Acid SCHEMBL16732003 | 0.98 | FOLH1 (0.56) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| Hydrochloric Acid SCHEMBL4067567 | 0.98 | FOLH1 (0.56) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| Methane SCHEMBL28201404 | 0.98 | FOLH1 (0.56) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| Ammonia Solution, Strong SCHEMBL6151757 | 0.98 | FOLH1 (0.56) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| Acetic Acid SCHEMBL5031583 | 0.94 | FOLH1 (0.53) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| SCHEMBL472937 | 0.93 | FOLH1 (0.50) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| SCHEMBL472934 | 0.93 | FOLH1 (0.50) | FOLH1GSRRNPEPSLC6A5CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114206902-B | Method for modifying peptides immobilized on a solid support by means of a traceless reducing cleavable linker molecule | 格瑞罗斯普罗泰恩科技公司 | 2025-02-21 | — | — | CN | claimed |
| EP-4313159-A1 | SYNTHETIC PEPTIDE SHUTTLE AGENT BIOCONJUGATES FOR INTRACELLULAR CARGO DELIVERY | Feldan Bio Inc. (CA) | 2024-02-07 | — | — | EP | claimed |
| US-20220363713-A1 | A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES | Belyntic GmbH (DE) | 2022-11-17 | — | — | US | claimed |
| WO-2022204806-A1 | SYNTHETIC PEPTIDE SHUTTLE AGENT BIOCONJUGATES FOR INTRACELLULAR CARGO DELIVERY | FELDAN BIO INC. (CA) | 2022-10-06 | — | — | WO | claimed |
| EP-4010352-A1 | A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES | Belyntic GmbH (DE) | 2022-06-15 | — | — | EP | claimed |
| CN-114206902-A | Method for modifying a peptide immobilized on a solid support by means of a traceless reductively cleavable linker molecule | 贝兰迪克有限责任公司 | 2022-03-18 | — | — | CN | claimed |
| EP-3956348-A1 | PEPTIDE-BASED NON-PROTEINACEOUS CARGO DELIVERY | Feldan Bio Inc. (CA) | 2022-02-23 | — | — | EP | claimed |
| WO-2021023892-A1 | A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES | Belyntic GmbH (DE) | 2021-02-11 | — | — | WO | claimed |
| WO-2020210916-A1 | PEPTIDE-BASED NON-PROTEINACEOUS CARGO DELIVERY | FELDAN BIO INC. (CA) | 2020-10-22 | — | — | WO | claimed |
| US-5753652-A | Antiretroviral hydrazine derivatives | NOVARTIS CORPORATION (US) | 1998-05-19 | — | — | US | claimed |
| US-20260062692-A1 | COMPOSITIONS AND METHODS FOR THE IMMOBILIZATION OF ENZYMES USING CROSSLINKED BIOMOLECULAR CONDENSATES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2026-03-05 | — | — | US | disclosed |
| EP-4680251-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | Thomas Jefferson University (US) | 2026-01-21 | — | — | EP | disclosed |
| US-12473328-B2 | Method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules | Belyntic GmbH (DE) | 2025-11-18 | — | — | US | disclosed |
| WO-2025106527-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FRIEDREICH'S ATAXIA | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2025-05-22 | — | — | WO | disclosed |
| CN-114206902-B | Method for modifying peptides immobilized on a solid support by means of a traceless reducing cleavable linker molecule | 格瑞罗斯普罗泰恩科技公司 | 2025-02-21 | — | — | CN | disclosed |
| US-6008228-A | COMPRISING A MIXTURE OF CARRIER MONOGLYCERIDES OF MEDIUM CHAIN-FATTY ACIDS | HOFFMAN-LA ROCHE INC. (US) | 1999-12-28 | — | — | US | disclosed |
| EP-0831826-A1 | PHARMACEUTICAL COMPOSITION COMPRISING A PROTEINASE INHIBITOR AND A MONOGLYCERIDE | F. HOFFMANN-LA ROCHE AG (CH) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996039142-A1 | PHARMACEUTICAL COMPOSITION COMPRISING A PROTEINASE INHIBITOR AND A MONOGLYCERIDE | F. HOFFMANN-LA ROCHE AG (CH) | 1996-12-12 | — | — | WO | disclosed |
| EP-0184550-A2 | 5-Amino-4-hydroxy valeryl amide derivatives | CIBA-GEIGY AG (CH) | 1986-06-11 | — | — | EP | disclosed |
| US-4092350-A | ANTIINFLAMMATORY AGENTS, RHEUMATIC DISEASES | TOYAMA CHEMICAL COMPANY LIMITED (JA) | 1978-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220363713-A1 | A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES | PTMS, VIP, HM13 | FOLH1 590/4885GSR 2054/4885RNPEP 14/4885 |
| US-12473328-B2 | Method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules | PTMS, VIP, HM13 | FOLH1 575/4885GSR 1720/4885RNPEP 13/4885 |
| US-20260062692-A1 | COMPOSITIONS AND METHODS FOR THE IMMOBILIZATION OF ENZYMES USING CROSSLINKED BIOMOLECULAR CONDENSATES | ADH5, ADH1C, ADH1A | FOLH1 1296/4885GSR 528/4885RNPEP 1140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.